A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment

• Status: Completed
• Trial end date: 2017-11-25
• Target enrollment: 0
• Participant gender: All

Summary

Dyspepsia is a very common but non-specific complaint that may indicate a group of symptoms that can be attributed to the upper gastrointestinal system, such as epigastric discomfort, abdominal bloating or fullness, stomach upset and nausea or vomiting that may be associated with food.

This study aimed to improve treatment management of patients with complaints of dyspeptic pain and emergency services, and to compare treatment efficacy of oral sucralfate, alginate and hydrotalcite, which are widely used in our country. Literature According to our research, our study is the first study to compare different antacids in our study of emergency serviste dyspepsia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pamukkale University
• Treatments: Alginic acid; Aluminum Hydroxide; Hydrotalcite; Magnesium Hydroxide; Sucralfate

Criteria

Inclusion Criteria:

• Stomach pain, swelling or dispeptic complaints.

• Men and women between the ages of 18-60.

• Patients with VAS> 5.

Exclusion Criteria:

• Pregnancy and lactation.

• Sucralfate, alginate, hydrotalcite allergy.

• Emergency service arrives with acute psychiatric symptoms.

• Gastrointestinal system bleedings.

• Chronic renal failure, liver cirrhosis, structural and functional heart disease.

• Gastric malignancy and terminal illness.

• Patients suspected of having a different problem such as ileus, biliary colic,

• pancreatitis, hepatitis.

• Patients who refuse to participate in the study.

• Those who can not use VAS.

• Presence of ischemic findings on the arrival ECG.